ESC Premium Access

Effect of pretreatment with P2Y12 receptor antagonists on mortality in patients undergoing PCI: A report from SCAAR

Presentation

About the speaker

Professor Elmir Omerovic

Sahlgrenska University Hospital, Gothenburg (Sweden)
10 presentations
0 follower

24 more presentations in this session

Gender differences in oral antiplatelet treatment use - results from a nationwide cohort study of acute coronary syndrome patients in Finland

Speaker: Doctor V. Kyto (Turku, Finland, FI)

Thumbnail

Prevalence and outcomes of prasugrel versus clopidogrel in patients with and without diabetes following percutaneous coronary intervention for acute coronary syndrome

Speaker: Doctor M. Faggioni (Nashville, US)

Thumbnail

Platelet reactivity and outcomes after transcatheter aortic valve implantation

Speaker: Doctor L. Gross (Munich, DE)

Thumbnail

Safety of a regional standardized protocol to optimize the use of most effective platelet inhibition in ACS treated with PCI : Final Results from the Multicenter Rijnmond Collective Cardiology Study

Speaker: Doctor M. Van Der Linden (Schiedam, NL)

Thumbnail

Characteristics and safety outcomes in first-time users of the P2Y12 receptor antagonists clopidogrel, prasugrel and ticagrelor

Speaker: Associate Professor S. Johansson (Molndal, SE)

Thumbnail

Access the full session

Poster session 2 - Clinical platelet studies

Speakers: Professor E. Omerovic, Doctor V. Kyto, Doctor M. Faggioni, Doctor L. Gross, Doctor M. Van Der Linden...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk